Overview

Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
There are cells in the skin and blood of humans with chronic moderate to severe plaque psoriasis with specific activities that may determine the effectiveness of treatment. These activities may be described by obtaining samples of skin and blood and analyzing them using a variety of tests.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Tofacitinib